Cannabis Extracts Worked Better Than Pure THC for MS and Epilepsy in Lab Tests | Research

The takeaway

Whole cannabis extracts produced faster-acting spasticity relief and more potent anticonvulsant effects than pure THC alone, with THC-free extracts also showing anticonvulsant activity, suggesting other plant compounds contribute to therapeutic effects.

Read this if you want to understand why whole-plant cannabis products may differ from isolated THC or CBD.

Whole extract more potent than pure THC for seizures; THC-free extract also anticonvulsant

What the researchers found

In a mouse model of MS, whole cannabis extract (SCE) and pure THC inhibited spasticity to comparable levels, but the extract produced faster onset of muscle relaxation and shorter time to maximum effect. THC-free extract and pure CBD did not reduce spasticity, confirming THC was necessary for this effect.

In an epilepsy model using rat brain slices, the whole extract was both more potent and faster-acting as an anticonvulsant than isolated THC. The THC-free extract also exhibited anticonvulsant activity in this model, though CBD alone did not. This demonstrated that some therapeutic effects of cannabis were enhanced by or even independent of THC, with unidentified plant compounds contributing.

Why it matters

This study provided some of the clearest early evidence that cannabis extracts contained therapeutically active compounds beyond THC and CBD. The finding that THC-free extract had anticonvulsant properties independent of CBD was particularly intriguing and suggested unidentified plant constituents with therapeutic potential.

The numbers in context

Cannabis extracts were compared at matched THC concentrations. Both spasticity and epilepsy models were tested with four preparations: full extract, THC alone, THC-free extract, and CBD alone.

How the study worked

This was a preclinical study comparing standardized cannabis extract (SCE), pure THC, THC-free extract, and CBD in two models: a mouse model of MS spasticity (CREAE) and an in vitro rat brain slice model of epilepsy (oxotremorine-M-induced seizures). All extract concentrations were matched for THC content.

What this study cannot tell us

Both models were preclinical (animal and in vitro). The specific compounds in THC-free extract responsible for anticonvulsant activity were not identified. The mouse spasticity model and brain slice epilepsy model may not fully predict human therapeutic responses.

How to read the evidence

This is a well-designed preclinical study using multiple models and controlled comparisons, providing moderate-level evidence.

When this study was published

Published in 2003. The concept that whole-plant extracts contain multiple active compounds has been supported by subsequent research.

The bigger picture

This research contributed to the scientific basis for the "entourage effect" and supported the development of whole-plant cannabis medicines rather than single-molecule drugs. The anticonvulsant findings predated the later success of CBD-based Epidiolex for epilepsy, though this study suggested non-CBD compounds also contributed to anticonvulsant effects.

Questions still open

What specific compounds in the THC-free extract were responsible for anticonvulsant activity? Would whole-plant extracts outperform isolated THC or CBD in human clinical trials for epilepsy?

Common questions

Is whole-plant cannabis better than pure THC?

In these lab models, whole-plant extracts worked faster for spasticity and were more potent against seizures than pure THC alone. This suggests other compounds in the plant contribute to or enhance therapeutic effects.

Can cannabis components other than THC and CBD treat seizures?

This study found that a THC-free cannabis extract had anticonvulsant activity that was not explained by CBD alone, suggesting other unidentified plant compounds contributed. These compounds have not been fully characterized.

Read the original research

Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects?

The Journal of pharmacy and pharmacology, 55(12), 1687-94

View on PubMed ↗

Citation

Wilkinson, J D; Whalley, B J; Baker, D; Pryce, G; Constanti, A; Gibbons, S; Williamson, E M. (2003). Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects?. The Journal of pharmacy and pharmacology, 55(12), 1687-94.